Add to My Stocks
$2.52 $0.29 (13%) HJLI stock closing price Sep 20, 2018 (Closing)
Fiscal year is Jan - Dec2018 Q22018 Q1
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow6.64M4.6M
Net Increase (Decrease) in Assets Liabilities--0.13M
Cash From (used in) Discontinued Operations--
Other Adjustments Net-0.41M-1.35M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment--
Acquisition Disposition of Subsidiaires--
Increase (Decrease) in Investments--
Other Cash Inflow (Outflow) from Investment Activities--
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares7.66M-
Issuance (Repayment) of Debt Securities2.08M2.2M
Increase (Decrease) in Bank & Other Borrowings--
Payment of Dividends & Other Cash Distributions--
Other Cash from (used by) Financing Activities-0.71M-0.34M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash--
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year--
Cash & Equivalents at Year End5.94M-
All figures in USD. M: Millions of USD, B: Billions of USD.

Key Financial Ratios For HANCOCK JAFFE Cash Flow

Quarterly Cash Flow Statements For HANCOCK JAFFE Peers

Cardax cash flow, Nuvo Pharmaceuticals cash flow, XTL Biopharma cash flow